Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety and Efficacy of Sodium Zirconium Cyclosilicate in Hyperkalemia
NCT02163499Phase 3Completed
- Sponsor
- ZS Pharma
- Start
- Jun 2014
- Primary completion
- Nov 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 7
01
Overview
A Phase 3 trial of sodium zirconium cyclosilicate in hyperkalemia, sponsored by ZS Pharma. Started Jun 2014; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT02163499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02163499.